- call +1-201-465-4211
- email sales@mrinsights.biz
Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
Scope of the Report:
This report focuses on the Combined hormonal contraceptive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
The worldwide market for Combined hormonal contraceptive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pills
Patch
Ring
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
There are 15 Chapters to deeply display the global Combined hormonal contraceptive market.
Chapter 1, to describe Combined hormonal contraceptive Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Combined hormonal contraceptive, with sales, revenue, and price of Combined hormonal contraceptive, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Combined hormonal contraceptive, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Combined hormonal contraceptive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Combined hormonal contraceptive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Combined hormonal contraceptive Introduction
1.2 Market Analysis by Type
1.2.1 Pills
1.2.2 Patch
1.2.3 Ring
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 E-commerce
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries
2.1.1 Business Overview
2.1.2 Combined hormonal contraceptive Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer HealthCare Pharmaceuticals
2.2.1 Business Overview
2.2.2 Combined hormonal contraceptive Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Actavis
2.3.1 Business Overview
2.3.2 Combined hormonal contraceptive Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Actavis Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Combined hormonal contraceptive Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Combined hormonal contraceptive Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Combined hormonal contraceptive Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Watson Pharma
2.7.1 Business Overview
2.7.2 Combined hormonal contraceptive Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Watson Pharma Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cipla
2.8.1 Business Overview
2.8.2 Combined hormonal contraceptive Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis International
2.9.1 Business Overview
2.9.2 Combined hormonal contraceptive Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis International Combined hormonal contraceptive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Combined hormonal contraceptive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Combined hormonal contraceptive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Combined hormonal contraceptive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Combined hormonal contraceptive Manufacturer Market Share in 2017
3.3.2 Top 6 Combined hormonal contraceptive Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Combined hormonal contraceptive Market Analysis by Regions
4.1 Global Combined hormonal contraceptive Sales, Revenue and Market Share by Regions
4.1.1 Global Combined hormonal contraceptive Sales and Market Share by Regions (2013-2018)
4.1.2 Global Combined hormonal contraceptive Revenue and Market Share by Regions (2013-2018)
4.2 North America Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
4.3 Europe Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
4.5 South America Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
5 North America Combined hormonal contraceptive by Countries
5.1 North America Combined hormonal contraceptive Sales, Revenue and Market Share by Countries
5.1.1 North America Combined hormonal contraceptive Sales and Market Share by Countries (2013-2018)
5.1.2 North America Combined hormonal contraceptive Revenue and Market Share by Countries (2013-2018)
5.2 United States Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
5.3 Canada Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
5.4 Mexico Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
6 Europe Combined hormonal contraceptive by Countries
6.1 Europe Combined hormonal contraceptive Sales, Revenue and Market Share by Countries
6.1.1 Europe Combined hormonal contraceptive Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Combined hormonal contraceptive Revenue and Market Share by Countries (2013-2018)
6.2 Germany Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
6.3 UK Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
6.4 France Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
6.5 Russia Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
6.6 Italy Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
7 Asia-Pacific Combined hormonal contraceptive by Countries
7.1 Asia-Pacific Combined hormonal contraceptive Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Combined hormonal contraceptive Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Combined hormonal contraceptive Revenue and Market Share by Countries (2013-2018)
7.2 China Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
7.3 Japan Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
7.4 Korea Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
7.5 India Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
8 South America Combined hormonal contraceptive by Countries
8.1 South America Combined hormonal contraceptive Sales, Revenue and Market Share by Countries
8.1.1 South America Combined hormonal contraceptive Sales and Market Share by Countries (2013-2018)
8.1.2 South America Combined hormonal contraceptive Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
8.3 Argentina Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
8.4 Colombia Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
9 Middle East and Africa Combined hormonal contraceptive by Countries
9.1 Middle East and Africa Combined hormonal contraceptive Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Combined hormonal contraceptive Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Combined hormonal contraceptive Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
9.3 UAE Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
9.4 Egypt Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
9.5 Nigeria Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
9.6 South Africa Combined hormonal contraceptive Sales and Growth Rate (2013-2018)
10 Global Combined hormonal contraceptive Market Segment by Type
10.1 Global Combined hormonal contraceptive Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Combined hormonal contraceptive Sales and Market Share by Type (2013-2018)
10.1.2 Global Combined hormonal contraceptive Revenue and Market Share by Type (2013-2018)
10.2 Pills Sales Growth and Price
10.2.1 Global Pills Sales Growth (2013-2018)
10.2.2 Global Pills Price (2013-2018)
10.3 Patch Sales Growth and Price
10.3.1 Global Patch Sales Growth (2013-2018)
10.3.2 Global Patch Price (2013-2018)
10.4 Ring Sales Growth and Price
10.4.1 Global Ring Sales Growth (2013-2018)
10.4.2 Global Ring Price (2013-2018)
11 Global Combined hormonal contraceptive Market Segment by Application
11.1 Global Combined hormonal contraceptive Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 E-commerce Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Combined hormonal contraceptive Market Forecast (2018-2023)
12.1 Global Combined hormonal contraceptive Sales, Revenue and Growth Rate (2018-2023)
12.2 Combined hormonal contraceptive Market Forecast by Regions (2018-2023)
12.2.1 North America Combined hormonal contraceptive Market Forecast (2018-2023)
12.2.2 Europe Combined hormonal contraceptive Market Forecast (2018-2023)
12.2.3 Asia-Pacific Combined hormonal contraceptive Market Forecast (2018-2023)
12.2.4 South America Combined hormonal contraceptive Market Forecast (2018-2023)
12.2.5 Middle East and Africa Combined hormonal contraceptive Market Forecast (2018-2023)
12.3 Combined hormonal contraceptive Market Forecast by Type (2018-2023)
12.3.1 Global Combined hormonal contraceptive Sales Forecast by Type (2018-2023)
12.3.2 Global Combined hormonal contraceptive Market Share Forecast by Type (2018-2023)
12.4 Combined hormonal contraceptive Market Forecast by Application (2018-2023)
12.4.1 Global Combined hormonal contraceptive Sales Forecast by Application (2018-2023)
12.4.2 Global Combined hormonal contraceptive Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Combined hormonal contraceptive Picture
Table Product Specifications of Combined hormonal contraceptive
Figure Global Sales Market Share of Combined hormonal contrac
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
